Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal supraventricular tachycardia
Flecainide is a class IC antiarrhythmic utilized in prophylaxis of refractory paroxysmal supraventricular tachycardias in pediatric populations. Despite being a highly effective agent, its narrow therapeutic index increases the risk of toxicity and proarrhythmic events, including wide-complex tachyc...
Saved in:
Main Authors: | Ronald Palmen (Author), Tracy Sandritter (Author), Lindsey Malloy-Walton (Author), Christopher Follansbee (Author), Jonathan B. Wagner (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flecainide intoxication in pediatric patients with supraventricular tachycardia
by: Guiem Vaquer, et al.
Published: (2020) -
Fetal Tachycardia in the Delivery Room: Fetal Distress, Supraventricular Tachycardia, or Both?
by: Satvinder Singh Bhatia, et al.
Published: (2020) -
The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias
by: Yakup Ergul, et al.
Published: (2015) -
Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital
by: Timothy A. Roberts, et al.
Published: (2021) -
Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know
by: Tracy Sandritter, et al.
Published: (2023)